Bank of America’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-118,871
| Closed | -$160K | – | 8049 |
|
|
2021
Q4 | $160K | Buy |
118,871
+101,100
| +569% | +$136K | ﹤0.01% | 5809 |
|
|
2021
Q3 | $51K | Buy |
17,771
+5,264
| +42% | +$15.1K | ﹤0.01% | 6150 |
|
|
2021
Q2 | $44K | Sell |
12,507
-5,631
| -31% | -$19.8K | ﹤0.01% | 6083 |
|
|
2021
Q1 | $62K | Buy |
18,138
+12,166
| +204% | +$41.6K | ﹤0.01% | 5877 |
|
|
2020
Q4 | $115K | Buy |
5,972
+631
| +12% | +$12.2K | ﹤0.01% | 5183 |
|
|
2020
Q3 | $71K | Sell |
5,341
-21,526
| -80% | -$286K | ﹤0.01% | 5220 |
|
|
2020
Q2 | $1.14M | Buy |
26,867
+132
| +0.5% | +$5.59K | ﹤0.01% | 3586 |
|
|
2020
Q1 | $737K | Buy |
26,735
+155
| +0.6% | +$4.27K | ﹤0.01% | 3730 |
|
|
2019
Q4 | $863K | Sell |
26,580
-6,690
| -20% | -$217K | ﹤0.01% | 3939 |
|
|
2019
Q3 | $867K | Buy |
33,270
+26,144
| +367% | +$681K | ﹤0.01% | 3964 |
|
|
2019
Q2 | $262K | Buy |
7,126
+3,726
| +110% | +$137K | ﹤0.01% | 4746 |
|
|
2019
Q1 | $76K | Sell |
3,400
-2,492
| -42% | -$55.7K | ﹤0.01% | 5264 |
|
|
2018
Q4 | $82K | Buy |
5,892
+4,216
| +252% | +$58.7K | ﹤0.01% | 5269 |
|
|
2018
Q3 | $32K | Buy |
1,676
+618
| +58% | +$11.8K | ﹤0.01% | 5627 |
|
|
2018
Q2 | $23K | Buy |
1,058
+468
| +79% | +$10.2K | ﹤0.01% | 5732 |
|
|
2018
Q1 | $13K | Buy |
+590
| New | +$13K | ﹤0.01% | 5779 |
|